Showing 1,451 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

US finds sharp rise in ‘pay-for-delay’ deals blocking generics

Editor's pick
Intellectual Property Watch
21 January 2013
Pharmaceutical industry

Médecins Sans Frontières addresses study by Massachusetts General Hospital on implications of switching from branded to generic antiretrovirals for HIV

Editor's pick
MSF / EATG
17 January 2013
Finance & funding

Study questions generic HIV drug use

Editor's pick
BBC Health
15 January 2013
Finance & funding

Generics Could Cut Costs of HIV Treatment

Editor's pick
MedPage Today HIV/AIDS
15 January 2013
New & experimental hepatitis C treatment

Achillion Continues To Make Significant Strides In The Fight Against Hepatitis C

Editor's pick
Seeking Alpha
15 January 2013
Bad science & bogus treatments

Nigerian texters to take on the drug counterfeiters

Editor's pick
BBC Health
11 January 2013
Pharmaceutical industry

Glaxo Says No Plan for Viiv Spinoff ‘at the Moment’

Editor's pick
Bloomberg
11 January 2013
New & experimental hepatitis C treatment

Idenix May Drop Delayed Hepatitis C Drug for New Versions

Editor's pick
Businessweek
10 January 2013
New & experimental hepatitis C treatment

Gilead Provides Update on Hepatitis C Development Programs

Editor's pick
Gilead press release
8 January 2013
New & experimental hepatitis C treatment

Achillion Reports Interim Results on ACH-3102

Editor's pick
Achillion press release
8 January 2013
Access to healthcare

Thai-EU Free Trade Agreement Raises Alarm for People With AIDS

Editor's pick
Inter Press Service
3 January 2013
New & experimental hepatitis C treatment

Medivir announces phase III data for Simeprevir demonstrating efficacy and safety in genotype 1 hepatitis C patients

Editor's pick
Medivir press release
20 December 2012
Clinical trials

Industry Funding Changes Study Results, Research Shows

Editor's pick
University of California press release
20 December 2012
New & experimental HIV treatments

ViiV Files Regulatory Applications for New Integrase Inhibitor Dolutegravir

Editor's pick
AIDSMeds
19 December 2012
New & experimental HIV treatments

ViiV Healthcare announces regulatory submissions for dolutegravir in the EU, US and Canada

Editor's pick
ViiV press release
18 December 2012
Pharmaceutical industry

Breaking Up With Gilead Sciences

Editor's pick
The Street
17 December 2012
Pharmaceutical industry

US: AIDS physician groups tell pharma to lower prices

Editor's pick
Pharmalot
12 December 2012
Access to healthcare

Thailand: Local HIV drugs offer lower prices

Editor's pick
Bangkok Post
10 December 2012
Access to healthcare

Brazil enters new era of co-production of anti-AIDS drugs

Editor's pick
Inter Press Service
10 December 2012
HIV treatment for children & young people

Childhood HIV Risks Becoming Neglected Disease As Fewer Children Born With HIV, Experts Warn

Editor's pick
Kaiser Daily Global Health Policy Report
6 December 2012
Access to healthcare

Advocates to drugmakers: Join Patent Pool or else

Editor's pick
Pharmalot
6 December 2012
Pharmaceutical industry

Copy of ITPC Open letter from activists in EECA about the Galien Prix Award goint to Merck for boceprevir

Editor's pick
GMI Partnership
6 December 2012
Pharmaceutical industry

ITPC Open letter from activists in EECA about the Galien Prix Award goint to Merck for boceprevir

Editor's pick
EATG
6 December 2012
Access to healthcare

UNITAID statement on Johnson & Johnson’s darunavir announcement

Editor's pick
UNITAID press release
5 December 2012